- From AM, Maleszewski JJ, Rihal CS. Current status of endomyocardial biopsy. Mayo Clin Proc. 2011;86(11):1095–1102. doi:https://doi.org/10.4065/mcp.2011.0296.
- Crespo-Leiro MG, Stypmann J, Schulz U, et al. Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II. Eur Heart J. 2016;37(33):2591–2601. doi:https://doi.org/10.1093/eurheartj/ehv682.
- Introduction to the HCUP National Inpatient Sample (NIS), 2012. Rockville, MD: Agency for Healthcare Research and Quality. https://www.hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2012.jsp. Published 2014, updated November 2015. Accessed November 1, 2020.
- Consumer price index (CPI) databases. Washington, DC: US Bureau of Labor Statistics. https://www.bls.gov/cpi/data.htm. Published May 2020. Accessed November 1, 2020.
- Saraiva F, Matos V, Gonçalves L, Antunes M, Providência L. Complications of endomyocardial biopsy in heart transplant patients: a retrospective study of 2117 consecutive procedures. Transplant Proc. 2011;43(5):1908–1912. doi:https://doi.org/10.1016/j.transproceed.2011.03.010.
- Fowles RE, Mason JW. Endomyocardial biopsy. Ann Intern Med. 1982;97(6):885–894. doi:https://doi.org/10.7326/0003-4819-97-6-885.
- Deckers JW, Hare JM, Baughman KL. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol. 1992;19(1):43–47. doi:https://doi.org/10.1016/0735-1097(92)90049-S.
- Singh V, Mendirichaga R, Savani GT, et al. Comparison of utilization trends, indications, and complications of endomyocardial biopsy in native versus donor hearts (from the Nationwide Inpatient Sample 2002 to 2014). Am J Cardiol. 2018;121(3):356–363. doi:https://doi.org/10.1016/j.amjcard.2017.10.021.
- Hollander Z, Mohammadi T, Assadian S, et al. Cost-effectiveness of a blood-based biomarker compared to endomyocardial biopsy for the diagnosis of acute allograft rejection. J Heart Lung Transplant. 2016;35(4):S53. doi:https://doi.org/10.1016/j.healun.2016.01.145.
- Rocca HPB-L, SüTsch G, Schneider J, Follath F, Kiowski W. Natural course of moderate cardiac allograft rejection (International Society for Heart Transplantation grade 2) early and late after transplantation. Circulation. 1996;94(6):1334–1338. doi:https://doi.org/10.1161/01.CIR.94.6.1334.
- Rapp N, Vandermey A. Here’s what every organ in the body would cost to transplant. Fortune, September 14, 2017. https://fortune.com/2017/09/14/organ-transplant-cost/.
- Lampert BC, Teuteberg JJ, Shullo MA, Holtz J, Smith KJ. Cost-effectiveness of routine surveillance endomyocardial biopsy after 12 months post-heart transplantation. Circ Heart Fail. 2014;7(5):807–813. doi:https://doi.org/10.1161/CIRCHEARTFAILURE.114.001199.
- Mark DB. Economics and cost-effectiveness in cardiology. In: Walsh R, Fang J, Fuster V, eds. Hurst’s the Heart Manual of Cardiology. 13th ed. New York: McGraw Hill; 2011:2389–2408.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 34, 2021 - Issue 3
Original Research
Trends in post–heart transplant biopsies for graft rejection versus nonrejection
Aayla K. Jamila Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, TexasCorrespondence[email protected]
https://orcid.org/0000-0001-9471-3383
, MBBS, MPHhttps://orcid.org/0000-0001-9471-3383, , MD, , MPH, , MPH, Joost Feliusb Annette C. and Harold C. Simmons Transplant Institute, Baylor Scott & White Research Institute, Dallas, Texashttps://orcid.org/0000-0001-7200-8755
, PhDhttps://orcid.org/0000-0001-7200-8755, , MD, Shelley A. Halla Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, Texas;b Annette C. and Harold C. Simmons Transplant Institute, Baylor Scott & White Research Institute, Dallas, Texashttps://orcid.org/0000-0002-5989-2934
, MDhttps://orcid.org/0000-0002-5989-2934 & , MD show all